CIAM
OLMA icon

Caitong International Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Caitong International Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29K Sell
183
-5,787
-97% -$77.5K ﹤0.01% 1388
2026
Q1 		$89K Buy
+5,970
New +$133K 0.02% 617
2025
Q2 		– Sell
-484
Closed -$1.82K – 2336
2025
Q1 		$1.82K Buy
484
+230
+91% +$1.16K ﹤0.01% 1388
2024
Q4 		$1.48K Buy
+254
New +$2.54K ﹤0.01% 1235

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Caitong International Asset Management's OLMA Position: Q2 2026 in Review

Caitong International Asset Management reduced its Olema Pharmaceuticals (OLMA) stake by 97% in Q2 2026, selling an estimated $77.5K and leaving 183 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1388.

Caitong International Asset Management first reported a position in OLMA in Q4 2024 and has held it in 4 quarters since. The position peaked at $89K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Caitong International Asset Management held 183 shares of Olema Pharmaceuticals worth $2.29K as of Q2 2026.
  • Caitong International Asset Management sold 5,787 Olema Pharmaceuticals shares in Q2 2026, an estimated $77.5K.
  • Olema Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1388 holding.
  • Caitong International Asset Management first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's Olema Pharmaceuticals position peaked at $89K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.